3.8 Editorial Material

Production of COVID-19 Antibody Concentrates Using Immunoadsorption

期刊

TRANSFUSIONSMEDIZIN
卷 12, 期 3, 页码 157-162

出版社

GEORG THIEME VERLAG KG
DOI: 10.1055/a-1720-8203

关键词

COVID-19 convalescent plasma; antibody donation; immunoadsorption; virus neutralisation

向作者/读者索取更多资源

Due to the unexpected outcomes in using convalescent plasma and its varying and often low concentrations of COVID-19 antibodies, German guidelines do not recommend its use. Instead, a strategy involving the selective collection and concentration of human immunoglobulins using immunoadsorption has been adopted.
For more than two years the whole world is suffering from the COVID-19 pandemic. Before introduction of vaccination strategies the administration of fresh frozen plasma from convalescent donors seemed a promising therapeutic approach, especially if administered during the early phase of disease. The outcomes in multicenter trials on huge cohorts, however, did not meet the expectations. This is one reason why German guidelines do not recommend the use of convalescent plasma. One explanation could be varying and often low concentrations of COVID-19 antibodies in a majority of plasma units at the beginning of plasma applications, which could account for the lack of a convincing clinical efficacy. Therefore, we follow a strategy to selectively collect and concentrate human immunoglobulins using immunoadsorption as the method of antibody donation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据